Insight Capital Research & Management »

Emergent BioSolutions shares owned by Insight Capital Research & Management

Quarter-by-quarter ownership of Emergent BioSolutions (EBS) shares owned by Insight Capital Research & Management from 13F filings

Historical chart of Insight Capital Research & Management investment in Emergent BioSolutions

Tip: Access up to 7 years of quarterly data

All positions including Emergent BioSolutions held by Insight Capital Research & Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Emergent BioSolutions by Insight Capital Research & Management

Quarter filed Position value Share count Share price at filing
2017-09-30 $1.3M 31k 40.46
2016-03-31 $7.4M 203k 36.35
2015-12-31 $8.3M 208k 40.01
2015-09-30 $5.9M 207k 28.49

More positions owned by Insight Capital Research & Management

Apple (AAPL)
Facebook Inc cl a (META)
Microsoft Corporation (MSFT)
Brink's Company (BCO)
Raytheon Company
Amazon (AMZN)
Align Technology (ALGN)
Servicenow (NOW)
Msci (MSCI)
Square Inc cl a (SQ)
Activision Blizzard
Rogers Corporation (ROG)
Blucora
Sherwin-Williams Company (SHW)
Boeing Company (BA)

View all positions for Insight Capital Research & Management

Top funds holding Emergent BioSolutions

Vanguard Group
Marshall Wace
Charles Schwab Investment Management
BlackRock
State Street Corporation
American Century Companies
Oak Hill Advisors
Invesco
Susquehanna International
Connor, Clark & Lunn Investment Management
Millennium Management
D. E. Shaw & Co
Assenagon Asset Management
Palisade Capital Management
Two Sigma Investments

View all funds holding Emergent BioSolutions